-
Mashup Score: 0Stroke | Feature | AHA/ASA Journals - 4 hour(s) ago
Hosted by Dr. Negar Asdaghi, each episode of Stroke’s monthly podcast, Stroke Alert, begins by posing key takeaway questions from featured articles in the current issue of Stroke. This is followed by a brief summary and analysis of these articles, as well as an interview with the author of one of these featured articles or with one of the Stroke
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Stroke | Feature | AHA/ASA Journals - 1 month(s) ago
Hosted by Dr. Negar Asdaghi, each episode of Stroke’s monthly podcast, Stroke Alert, begins by posing key takeaway questions from featured articles in the current issue of Stroke. This is followed by a brief summary and analysis of these articles, as well as an interview with the author of one of these featured articles or with one of the Stroke
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0Stroke | Feature | AHA/ASA Journals - 2 month(s) ago
Hosted by Dr. Negar Asdaghi, each episode of Stroke’s monthly podcast, Stroke Alert, begins by posing key takeaway questions from featured articles in the current issue of Stroke. This is followed by a brief summary and analysis of these articles, as well as an interview with the author of one of these featured articles or with one of the Stroke
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Stroke Alert February 2024 - 3 month(s) ago
Negar Asdaghi, MD, MSc Eric D. Goldstein, MD Nastajjia Krementz, MD Dr. Negar Asdaghi: Let’s start with some questions. 1) Are the outcomes of endovascularly treated patients with a posterior circulation occlusion better in those pretreated with intravenous lytic therapy? 2) What is asundexian, and why should stroke physicians be aware of this new novel direct oral anticoagulant agent? 2) And finally, does the future of secondary prevention for symptomatic intracranial atherosclerotic disease entail
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Stroke Alert February 2024 - 3 month(s) ago
Negar Asdaghi, MD, MSc Eric D. Goldstein, MD Nastajjia Krementz, MD Dr. Negar Asdaghi: Let’s start with some questions. 1) Are the outcomes of endovascularly treated patients with a posterior circulation occlusion better in those pretreated with intravenous lytic therapy? 2) What is asundexian, and why should stroke physicians be aware of this new novel direct oral anticoagulant agent? 2) And finally, does the future of secondary prevention for symptomatic intracranial atherosclerotic disease entail
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Stroke Alert October 2023 - 7 month(s) ago
Negar Asdaghi, MD, MSc Eric D. Goldstein, MD Nastajjia Krementz, MD Dr. Negar Asdaghi: Let’s start with some questions. 1) Can spreading depolarization be good for the brain in the setting of intracerebral hemorrhage? 2) What are the highlights of the recently published guidelines for treatment of patients with aneurysmal subarachnoid hemorrhage? 3) And finally, can the pattern of cerebral microbleeds be used as a marker for how much amyloid is present in the brain? These are some of the questions that
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
For past episodes and to subscribe to the podcast, visit: https://t.co/T2ud57A96Z @EricGoldsteinMD @NKrementzMD @DanielleBCross #AHAJournals #StayAlertWithStrokeAlert